Steroids After Laser Trabeculoplasty for Glaucoma

Steroids And Laser Trabeculoplasty (SALT) Trial: Effect of Anti-Inflammatory Treatment on the Efficacy of SLT

The purpose of this study is to determine whether the choice of post-operative eye drop administered after selective laser trabeculoplasty (SLT) for glaucoma affects the efficacy in lowering intraocular pressure (IOP).

SLT is used to lower intraocular pressure in glaucoma, but it is not know whether the choice of eyedrops administered in the post-operative period affects SLT efficacy. Practitioners commonly use steroid drops, non-steroidal anti-inflammatory drops, or no drops at all. This is a randomized, single-center, prospective, masked clinical trial to determine whether the choice of eyedrop affects efficacy of SLT in glaucoma patients.

Inclusion Criteria:

• clinical diagnosis of glaucoma
• clinician has determined that SLT laser is indicated
• IOP currently >18 and was ever >21 in the past (e.g. prior to treatment)

Exclusion Criteria:

• prior history of uveitis
• prior glaucoma surgery including glaucoma laser surgery
• pregnant or 3 months post-partum